TRTiago Ribeiro

Tiago Ribeiro

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Tiago Ribeiro has a total of 176 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Artificial Intelligence and Endobronchial Ultrasound for Lymph-Node Detection and Characterization: A Pioneer Multicenter Transatlantic Study

    by Miguel Mascarenhas, Gema Diaz Nuevo, Sara Lopes, Juan Puertas Sancho, Cristina Lopez Garcia-Gallo, Luiza Bicudo de Oliveira, Miriam Chinzon, Larissa Mercadante de Assis, Gustavo Ejima, Fauze Maluf-Filho, et al.

    Background/Objectives: Accurate mediastinal and hilar lymph node (LN) assessment is central to lung cancer staging and treatment selection. Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) has become the standard minimally invasive procedure for mediastinal staging, enabling real-time identification, characterization and sampling of LNs. Although effective, this technique remains operator dependent, and subject to interobserver variability. This study aims to report the development of a Vision Transformer-based AI model for automatic LN detection and classification on EBUS images. Methods: A multicenter, multidevice, retrospective study, using EBUS images of three referral centers (Spain and Brazil). The dataset included images of patients with benign and malignant LNs. Bounding-box annotations were applied for LN localization, and LNs were classified as benign or malignant according to histopathologic reference standards. Detection performance was evaluated with mean average precision, at an intersection over union threshold of 0.5 (mAP50). Characterization performance was assessed using accuracy, sensitivity, specificity, and area under the receiver operating characteristic curve (AUROC). Results: The dataset included 6492 images from 27 patients, of whom 16 had malignant LNs. In the test set, the model achieved a mAP50 of 0.79 for LN detection. For malignant characterization, the model achieved an accuracy of 90.6%, sensitivity of 85.4%, and an AUROC of 0.938. Conclusions: The results of this study support the feasibility of AI-assisted EBUS interpretation for nodal staging workflows and raise the possibility that AI-assisted EBUS could enhance diagnostic performance, while reducing operator variability. Larger prospective studies are needed before clinical implementation.

  • Open Access

    Clinical Validation of AI-Assisted Evaluation of Indeterminate Biliary Strictures in Digital-Single Operator Cholangioscopy: A Transcontinental Multicentric Study

    by Miguel Mascarenhas, Jessica Widmer, Francisco Mendes, Tiago Ribeiro, Antonio Pinto da Costa, Belén Agudo, Miguel Martins, João Afonso, Joana Mota, Maria João Almeida, et al.

    INTRODUCTION: Biliary strictures (BS) are a significant challenge, with malignant strictures frequently diagnosed at advanced stages, limiting curative options. Digital single-operator cholangioscopy (D-SOC) enables high-resolution, direct visualization of the bile duct, yet with suboptimal accuracy. Artificial intelligence (AI) has shown promise for detection and differentiation of BS in frame-level analysis and small clinical series. This study aimed to validate a deep learning model for AI-assisted D-SOC image analysis. METHODS: This multicenter study included 135 D-SOC examinations from 129 patients (61 with malignant BS) across 14 centers in the United States, Brazil, Spain, Colombia, Australia, and Saudi Arabia. For each examination, up to 25 clinically relevant frames were selected and uploaded to a web-based platform for AI analysis. The model performed both detection and differentiation of BS: Detection was assessed by comparing AI-generated bounding boxes with expert-defined annotations using intersection-over-union (IoU), while differentiation was benchmarked against histopathology. Performance metrics included accuracy, sensitivity, specificity, and positive and negative predictive values. RESULTS: At the patient level, malignant BS were identified with 86.0% accuracy, 84.1% sensitivity, and 85.7% specificity, with an area under the curve of 0.904. The model demonstrated robust detection performance, achieving a mean IoU of 70.3%. Performance was maintained across demographic variables and centers. DISCUSSION: This first multicentric validation study demonstrates real-world performance of AI-assisted D-SOC analysis across multiples continents and devices, with robust accuracy for BS detection and differentiation. These findings support AI as an adjunctive tool in D-SOC, enhancing a more accurate evaluation of patients with indeterminate BS.


  • Open Access

    Correction: Saraiva et al. Deep Learning and High-Resolution Anoscopy: Development of an Interoperable Algorithm for the Detection and Differentiation of Anal Squamous Cell Carcinoma Precursors—A Multicentric Study. Cancers 2024, 16, 1909

    by Miguel Mascarenhas Saraiva, Lucas Spindler, Thiago Manzione, Tiago Ribeiro, Nadia Fathallah, Miguel Martins, Pedro Cardoso, Francisco Mendes, Joana Fernandes, João Ferreira, et al.

    There were errors in the original publication

  • Endoscopic ultrasound through-the-needle biopsy of pancreatic cystic neoplasms: Update on indications, safety profile, and research directions

    by Joana Mota, Tiago Ribeiro, Maria Cristina Conti Bellocchi, Nicolò De Pretis, Luca Frulloni, Joanne Lopes, Sokol Sina, Jahnvi Dhar, Jayanta Samanta, Guilherme Macedo, et al.


  • Open Access

    Artificial Intelligence for Lymph Node Detection and Malignancy Prediction in Endoscopic Ultrasound: A Multicenter Study

    by Belén Agudo Castillo, Miguel Mascarenhas Saraiva, António Miguel Martins Pinto da Costa, João Ferreira, Miguel Martins, Francisco Mendes, Pedro Cardoso, Joana Mota, Maria João Almeida, João Afonso, et al.

    Background/Objectives: Endoscopic ultrasound (EUS) is crucial for lymph node (LN) characterization, playing a key role in oncological staging and treatment guidance. EUS criteria for predicting malignancy are imprecise, and histologic diagnosis may have limitations. This multicenter study aimed to evaluate the effectiveness of a novel artificial intelligence (AI)–based system in predicting LN malignancy from EUS images. Methods: This multicenter study included EUS images from nine centers. Lesions were labeled (“malignant” or “benign”) and delimited with bounding boxes. Definitive diagnoses were based on cytology/biopsy or surgical specimens and, if negative, a minimum six-month clinical follow-up. A convolutional neural network (CNN) was developed using the YOLO (You Only Look Once) architecture, incorporating both detection and classification modules. Results: A total of 59,992 images from 82 EUS procedures were analyzed. The CNN distinguished malignant from benign lymph nodes with a sensitivity of 98.8% (95% CI: 98.5–99.2%), specificity of 99.0% (95% CI: 98.3–99.7%), and precision of 99.0% (95% CI: 98.4–99.7%). The negative and positive predictive values for malignancy were 98.8% and 99.0%, respectively. Overall diagnostic accuracy was 98.3% (95% CI: 97.6–99.1%). Conclusions: This is the first study evaluating the performance of deep learning systems for LN assessment using EUS imaging. Our AI-powered imaging model shows excellent detection and classification capabilities, emphasizing its potential to provide a valuable tool to refine LN evaluation with EUS, ultimately supporting more tailored, efficient patient care.


  • Open Access

    Unlocking the Potential of AI in EUS and ERCP: A Narrative Review for Pancreaticobiliary Disease

    by Catarina Cardoso Araújo, Joana Frias, Francisco Mendes, Miguel Martins, Joana Mota, Maria João Almeida, Tiago Ribeiro, Guilherme Macedo, Miguel Mascarenhas

    Artificial Intelligence (AI) is transforming pancreaticobiliary endoscopy by enhancing diagnostic accuracy, procedural efficiency, and clinical outcomes. This narrative review explores AI’s applications in endoscopic ultrasound (EUS) and endoscopic retrograde cholangiopancreatography (ERCP), emphasizing its potential to address diagnostic and therapeutic challenges in pancreaticobiliary diseases. In EUS, AI improves pancreatic mass differentiation, malignancy prediction, and landmark recognition, demonstrating high diagnostic accuracy and outperforming traditional guidelines. In ERCP, AI facilitates precise biliary stricture identification, optimizes procedural techniques, and supports decision-making through real-time data integration, improving ampulla recognition and predicting cannulation difficulty. Additionally, predictive analytics help mitigate complications like post-ERCP pancreatitis. The future of AI in pancreaticobiliary endoscopy lies in multimodal data fusion, integrating imaging, genomic, and molecular data to enable personalized medicine. However, challenges such as data quality, external validation, clinician training, and ethical concerns—like data privacy and algorithmic bias—must be addressed to ensure safe implementation. By overcoming these challenges, AI has the potential to redefine pancreaticobiliary healthcare, improving diagnostic accuracy, therapeutic outcomes, and personalized care.


  • Open Access

    Evaluating ChatGPT-4 for the Interpretation of Images from Several Diagnostic Techniques in Gastroenterology

    by Miguel Mascarenhas Saraiva, Tiago Ribeiro, Belén Agudo, João Afonso, Francisco Mendes, Miguel Martins, Pedro Cardoso, Joana Mota, Maria Joao Almeida, António Costa, et al.

    Background: Several artificial intelligence systems based on large language models (LLMs) have been commercially developed, with recent interest in integrating them for clinical questions. Recent versions now include image analysis capacity, but their performance in gastroenterology remains untested. This study assesses ChatGPT-4’s performance in interpreting gastroenterology images. Methods: A total of 740 images from five procedures—capsule endoscopy (CE), device-assisted enteroscopy (DAE), endoscopic ultrasound (EUS), digital single-operator cholangioscopy (DSOC), and high-resolution anoscopy (HRA)—were included and analyzed by ChatGPT-4 using a predefined prompt for each. ChatGPT-4 predictions were compared to gold standard diagnoses. Statistical analyses included accuracy, sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and area under the curve (AUC). Results: For CE, ChatGPT-4 demonstrated accuracies ranging from 50.0% to 90.0%, with AUCs of 0.50–0.90. For DAE, the model demonstrated an accuracy of 67.0% (AUC 0.670). For EUS, the system showed AUCs of 0.488 and 0.550 for the differentiation between pancreatic cystic and solid lesions, respectively. The LLM differentiated benign from malignant biliary strictures with an AUC of 0.550. For HRA, ChatGPT-4 showed an overall accuracy between 47.5% and 67.5%. Conclusions: ChatGPT-4 demonstrated suboptimal diagnostic accuracies for image interpretation across several gastroenterology techniques, highlighting the need for continuous improvement before clinical adoption.


  • Top Cited Papers
    Open Access

    Explainable AI in Digestive Healthcare and Gastrointestinal Endoscopy

    by Miguel Mascarenhas, Francisco Mendes, Miguel Martins, Tiago Ribeiro, João Afonso, Pedro Cardoso, João Ferreira, João Fonseca, Guilherme Macedo

    An important impediment to the incorporation of artificial intelligence-based tools into healthcare is their association with so-called black box medicine, a concept arising due to their complexity and the difficulties in understanding how they reach a decision. This situation may compromise the clinician’s trust in these tools, should any errors occur, and the inability to explain how decisions are reached may affect their relationship with patients. Explainable AI (XAI) aims to overcome this limitation by facilitating a better understanding of how AI models reach their conclusions for users, thereby enhancing trust in the decisions reached. This review first defined the concepts underlying XAI, establishing the tools available and how they can benefit digestive healthcare. Examples of the application of XAI in digestive healthcare were provided, and potential future uses were proposed. In addition, aspects of the regulatory frameworks that must be established and the ethical concerns that must be borne in mind during the development of these tools were discussed. Finally, we considered the challenges that this technology faces to ensure that optimal benefits are reaped, highlighting the need for more research into the use of XAI in this field.


  • Open Access

    Deep Learning and Automatic Detection of Pleomorphic Esophageal Lesions—A Necessary Step for Minimally Invasive Panendoscopy

    by Miguel Martins, Miguel Mascarenhas, Maria João Almeida, João Afonso, Tiago Ribeiro, Pedro Cardoso, Francisco Mendes, Joana Mota, Patrícia Andrade, Hélder Cardoso, et al.

    Background: Capsule endoscopy (CE) improved the digestive tract assessment; yet, its reading burden is substantial. Deep-learning (DL) algorithms were developed for the detection of enteric and gastric lesions. Nonetheless, their application in the esophagus lacks evidence. The study aim was to develop a DL model for esophageal pleomorphic lesion (PL) detection. Methods: A bicentric retrospective study was conducted using 598 CE exams. Three different CE devices provided 7982 esophageal frames, including 2942 PL lesions. The data were divided into the training/validation and test groups, in a patient-split design. Three runs were conducted, each with unique patient sets. The sensitivity, specificity, accuracy, positive and negative predictive value (PPV and NPV), area under the conventional receiver operating characteristic curve (AUC-ROC), and precision–recall curve (AUC-PR) were calculated per run. The model’s diagnostic performance was assessed using the median and range values. Results: The median sensitivity, specificity, PPV, and NPV were 75.8% (63.6–82.1%), 95.8% (93.7–97.9%), 71.9% (50.0–90.1%), and 96.4% (94.2–97.6%), respectively. The median accuracy was 93.5% (91.8–93.8%). The median AUC-ROC and AUC-PR were 0.82 and 0.93. Conclusions: This study focused on the automatic detection of pleomorphic esophageal lesions, potentially enhancing the diagnostic yield of this type of lesion, compared to conventional methods. Specific esophageal DL algorithms may provide a significant contribution and bridge the gap for the implementation of minimally invasive CE-enhanced panendoscopy.

  • Open Access

    Artificial Intelligence and Colposcopy: Automatic Identification of Vaginal Squamous Cell Carcinoma Precursors

    by Miguel Mascarenhas, Inês Alencoão, Maria João Carinhas, Miguel Martins, Tiago Ribeiro, Francisco Mendes, Pedro Cardoso, Maria João Almeida, Joana Mota, Joana Fernandes, et al.

    Background/Objectives: While human papillomavirus (HPV) is well known for its role in cervical cancer, it also affects vaginal cancers. Although colposcopy offers a comprehensive examination of the female genital tract, its diagnostic accuracy remains suboptimal. Integrating artificial intelligence (AI) could enhance the cost-effectiveness of colposcopy, but no AI models specifically differentiate low-grade (LSILs) and high-grade (HSILs) squamous intraepithelial lesions in the vagina. This study aims to develop and validate an AI model for the differentiation of HPV-associated dysplastic lesions in this region. Methods: A convolutional neural network (CNN) model was developed to differentiate HSILs from LSILs in vaginoscopy (during colposcopy) still images. The AI model was developed on a dataset of 57,250 frames (90% training/validation [including a 5-fold cross-validation] and 10% testing) obtained from 71 procedures. The model was evaluated based on its sensitivity, specificity, accuracy and area under the receiver operating curve (AUROC). Results: For HSIL/LSIL differentiation in the vagina, during the training/validation phase, the CNN demonstrated a mean sensitivity, specificity and accuracy of 98.7% (IC95% 96.7–100.0%), 99.1% (IC95% 98.1–100.0%), and 98.9% (IC95% 97.9–99.8%), respectively. The mean AUROC was 0.990 ± 0.004. During testing phase, the sensitivity was 99.6% and 99.7% for both specificity and accuracy. Conclusions: This is the first globally developed AI model capable of HSIL/LSIL differentiation in the vaginal region, demonstrating high and robust performance metrics. Its effective application paves the way for AI-powered colposcopic assessment across the entire female genital tract, offering a significant advancement in women’s healthcare worldwide.